Suppr超能文献

眼睑淋巴细胞浸润三例

Three Cases of Lymphocytic Infiltration of the Eyelid.

作者信息

Sugioka Kyoko, Hayashi Akinobu, Ichishi Masako, Sugimoto Yasuko, Habe Koji, Yamanaka Keiichi

机构信息

Department of Dermatology, Graduate School of Medicine, Mie University, Tsu, Mie 514-8507, Japan.

Department of Oncologic Pathology, Graduate School of Medicine, Mie University, Tsu, Mie 514-8507, Japan.

出版信息

Dermatopathology (Basel). 2021 May 8;8(2):124-129. doi: 10.3390/dermatopathology8020018.

Abstract

Lymphocytic infiltration of the skin (LIS), first reported by Jessner and Kanof in 1953, is a disease of unknown etiology characterized by erythematous papules and plaques on the head, neck, and upper back and histopathological findings of a normal epidermis with underlying lymphocytic infiltration of the reticular dermis without mucin deposition. A 69-year-old man and a 21-year-old woman presented with edematous indurative erythema of the left upper eyelid. Lymphocytic infiltration of the dermis with CD4+ T cell predominance was noted on biopsy. A 68-year-old man presented with a four-year history of recurrent edematous indurative erythema of the right upper eyelid that extended up to the right cheek. Predominantly dermal infiltration of CD8+ T lymphocytes was found on biopsy. We treated all three patients with 8-16 mg of methylprednisolone daily, and the erythema and induration improved. CD4+ T cells were predominant in the acute phase (patients 1 and 2), whereas CD8+ T cells were predominant in the chronic phase (patient 3). CD8+ T cells may be involved in LIS recurrence. Lymphocytic infiltration of the eyelid may be associated with isolated circumscribed, edematous, indurative, colorless lesions that are responsive to daily low-to-middle doses of oral methylprednisolone.

摘要

皮肤淋巴细胞浸润症(LIS)于1953年由杰斯纳(Jessner)和卡诺夫(Kanof)首次报道,是一种病因不明的疾病,其特征为头、颈和上背部出现红斑丘疹和斑块,组织病理学表现为表皮正常,网状真皮有淋巴细胞浸润但无黏蛋白沉积。一名69岁男性和一名21岁女性表现为左上眼睑水肿性硬结红斑。活检发现真皮淋巴细胞浸润,以CD4 + T细胞为主。一名68岁男性有右上眼睑反复出现水肿性硬结红斑4年的病史,该红斑向上延伸至右脸颊。活检发现主要为CD8 + T淋巴细胞的真皮浸润。我们对所有三名患者每日使用8 - 16毫克甲泼尼龙进行治疗,红斑和硬结均有改善。急性期(患者1和2)以CD4 + T细胞为主,而慢性期(患者3)以CD8 + T细胞为主。CD8 + T细胞可能与LIS复发有关。眼睑淋巴细胞浸润可能与孤立的、边界清晰的、水肿性的、硬结性的、无色病变有关,这些病变对每日低至中等剂量的口服甲泼尼龙有反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1d3/8161816/1efec3f41a40/dermatopathology-08-00018-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验